Majid Mokhtari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Majid Mokhtari has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Mohammad Esmaeil Akbari
Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 shared publicationsSamane Khoshbakht
Department of Bioinformatics, Kish International Campus, University of Tehran, Kish Island, Iran
3 shared publicationsKobra Ziyaei
Department of Bioinformatics, Kish International Campus, University of Tehran, Kish Island, Iran
2 shared publications- Kobra Ziyaei
Department of Fisheries, Faculty of Natural Resources, University of Tehran, Karaj, Iran
2 shared publications Sayyed Sajjad Moravveji
Department of Bioinformatics, Kish International Campus, University of Tehran, Kish Island, Iran
2 shared publications- Atieh Akbari
Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 3 November 2026
- Published by Brieflands in International Journal of Cancer Management
- Vol. 19 (1) , e175794
Non-coding RNAs in Cancer: From Computational Discovery to Functional Validation and Clinical Translation
- 3 November 2026
- Published by Brieflands in International Journal of Cancer Management
- Vol. 19 (1) , e175794
Open AccessNon-coding RNAs in Cancer: From Computational Discovery to Functional Validation and Clinical Translation
- Open Access
- 4 August 2025
- Published by Springer Nature in npj Microgravity
- Vol. 11 (1) , 52
Space-driven ROS in cells: a hidden danger to astronaut health and food safety
Astronaut nutrition faces supply, logistics, and cost challenges, making space farming a solution. While plants adapt to space microgravity may trigger oxidative stress. Research shows space-grown plants achieve Earth-like growth, but ROS accumulation remains a concern. This study examines ROS buildup in cells and its risks for astronauts, emphasizing effects on homeostasis, disease pathways, gut microbiome, and nutrition. This research provides new insights into oxidative stress in space missions.
- 4 August 2025
- Published by Springer Nature in npj Microgravity
- Vol. 11 (1) , 52
Open AccessSpace-driven ROS in cells: a hidden danger to astronaut health and food safety
Astronaut nutrition faces supply, logistics, and cost challenges, making space farming a solution. While plants adapt to space microgravity may trigger oxidative stress. Research shows space-grown plants achieve Earth-like growth, but ROS accumulation remains a concern. This study examines ROS buildup in cells and its risks for astronauts, emphasizing effects on homeostasis, disease pathways, gut microbiome, and nutrition. This research provides new insights into oxidative stress in space missions.
- 28 February 2024
- Published by Elsevier in Science of The Total Environment
- Vol. 924, 171261
Association between exposure to water sources contaminated with polycyclic aromatic hydrocarbons and cancer risk: A systematic review
- 28 February 2024
- Published by Elsevier in Science of The Total Environment
- Vol. 924, 171261
Association between exposure to water sources contaminated with polycyclic aromatic hydrocarbons and cancer risk: A systematic review
- Open Access
- 22 January 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 25 (2)
New classifications for quantum bioinformatics: Q-bioinformatics, QCt-bioinformatics, QCg-bioinformatics, and QCr-bioinformatics
Bioinformatics has revolutionized biology and medicine by using computational methods to analyze and interpret biological data. Quantum mechanics has recently emerged as a promising tool for the analysis of biological systems, leading to the development of quantum bioinformatics. This new field employs the principles of quantum mechanics, quantum algorithms, and quantum computing to solve complex problems in molecular biology, drug design, and protein folding. However, the intersection of bioinformatics, biology, and quantum mechanics presents unique challenges. One significant challenge is the possibility of confusion among scientists between quantum bioinformatics and quantum biology, which have similar goals and concepts. Additionally, the diverse calculations in each field make it difficult to establish boundaries and identify purely quantum effects from other factors that may affect biological processes. This review provides an overview of the concepts of quantum biology and quantum mechanics and their intersection in quantum bioinformatics. We examine the challenges and unique features of this field and propose a classification of quantum bioinformatics to promote interdisciplinary collaboration and accelerate progress. By unlocking the full potential of quantum bioinformatics, this review aims to contribute to our understanding of quantum mechanics in biological systems.
- 22 January 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 25 (2)
Open AccessNew classifications for quantum bioinformatics: Q-bioinformatics, QCt-bioinformatics, QCg-bioinformatics, and QCr-bioinformatics
Bioinformatics has revolutionized biology and medicine by using computational methods to analyze and interpret biological data. Quantum mechanics has recently emerged as a promising tool for the analysis of biological systems, leading to the development of quantum bioinformatics. This new field employs the principles of quantum mechanics, quantum algorithms, and quantum computing to solve complex problems in molecular biology, drug design, and protein folding. However, the intersection of bioinformatics, biology, and quantum mechanics presents unique challenges. One significant challenge is the possibility of confusion among scientists between quantum bioinformatics and quantum biology, which have similar goals and concepts. Additionally, the diverse calculations in each field make it difficult to establish boundaries and identify purely quantum effects from other factors that may affect biological processes. This review provides an overview of the concepts of quantum biology and quantum mechanics and their intersection in quantum bioinformatics. We examine the challenges and unique features of this field and propose a classification of quantum bioinformatics to promote interdisciplinary collaboration and accelerate progress. By unlocking the full potential of quantum bioinformatics, this review aims to contribute to our understanding of quantum mechanics in biological systems.
- Open Access
- 3 January 2024
- Published by Springer Nature in BMC Medical Genomics
- Vol. 17 (1) , 1
Correction: BMC3PM: bioinformatics multidrug combination protocol for personalized precision medicine and its application in cancer treatment
- 3 January 2024
- Published by Springer Nature in BMC Medical Genomics
- Vol. 17 (1) , 1
Open AccessCorrection: BMC3PM: bioinformatics multidrug combination protocol for personalized precision medicine and its application in cancer treatment
- Open Access
- 12 December 2023
- Published by Springer Nature in BMC Medical Genomics
- Vol. 16 (1) , 1-15
BMC3PM: bioinformatics multidrug combination protocol for personalized precision medicine and its application in cancer treatment
Background: In recent years, drug screening has been one of the most significant challenges in the field of personalized medicine, particularly in cancer treatment. However, several new platforms have been introduced to address this issue, providing reliable solutions for personalized drug validation and safety testing. In this study, we developed a personalized drug combination protocol as the primary input to such platforms. Methods: To achieve this, we utilized data from whole-genome expression profiles of 6173 breast cancer patients, 312 healthy individuals, and 691 drugs. Our approach involved developing an individual pattern of perturbed gene expression (IPPGE) for each patient, which was used as the basis for drug selection. An algorithm was designed to extract personalized drug combinations by comparing the IPPGE and drug signatures. Additionally, we employed the concept of drug repurposing, searching for new benefits of existing drugs that may regulate the desired genes. Results: Our study revealed that drug combinations obtained from both specialized and non-specialized cancer medicines were more effective than those extracted from only specialized medicines. Furthermore, we observed that the individual pattern of perturbed gene expression (IPPGE) was unique to each patient, akin to a fingerprint. Conclusions: The personalized drug combination protocol developed in this study offers a methodological interface between drug repurposing and combination drug therapy in cancer treatment. This protocol enables personalized drug combinations to be extracted from hundreds of drugs and thousands of drug combinations, potentially offering more effective treatment options for cancer patients.
- 12 December 2023
- Published by Springer Nature in BMC Medical Genomics
- Vol. 16 (1) , 1-15
Open AccessBMC3PM: bioinformatics multidrug combination protocol for personalized precision medicine and its application in cancer treatment
Background: In recent years, drug screening has been one of the most significant challenges in the field of personalized medicine, particularly in cancer treatment. However, several new platforms have been introduced to address this issue, providing reliable solutions for personalized drug validation and safety testing. In this study, we developed a personalized drug combination protocol as the primary input to such platforms. Methods: To achieve this, we utilized data from whole-genome expression profiles of 6173 breast cancer patients, 312 healthy individuals, and 691 drugs. Our approach involved developing an individual pattern of perturbed gene expression (IPPGE) for each patient, which was used as the basis for drug selection. An algorithm was designed to extract personalized drug combinations by comparing the IPPGE and drug signatures. Additionally, we employed the concept of drug repurposing, searching for new benefits of existing drugs that may regulate the desired genes. Results: Our study revealed that drug combinations obtained from both specialized and non-specialized cancer medicines were more effective than those extracted from only specialized medicines. Furthermore, we observed that the individual pattern of perturbed gene expression (IPPGE) was unique to each patient, akin to a fingerprint. Conclusions: The personalized drug combination protocol developed in this study offers a methodological interface between drug repurposing and combination drug therapy in cancer treatment. This protocol enables personalized drug combinations to be extracted from hundreds of drugs and thousands of drug combinations, potentially offering more effective treatment options for cancer patients.
- 10 July 2023
- Published by Elsevier in Phytomedicine
- Vol. 119, 154964
Phycocyanin as a nature-inspired antidiabetic agent: A systematic review
- 10 July 2023
- Published by Elsevier in Phytomedicine
- Vol. 119, 154964
Phycocyanin as a nature-inspired antidiabetic agent: A systematic review